Atherosclerosis and Lipoproteins |
-Tocopherol Combination Does Not Inhibit Atherogenesis in an ApoEDeficient Mouse Model
From the Institute of Lipid and Atherosclerosis Research (A.S., P.K., H.L., D.H.) and Research Unit of Autoimmune Diseases (J.G., B.G.), Department of Medicine `B', Sheba Medical Center, Tel-Hashomer and Sackler Faculty of Medicine, Tel Aviv University, Israel.
Correspondence to Dror Harats, MD, Institute of Lipid and Atherosclerosis Research, Sheba Medical Center, Tel-Hashomer, 52621, Israel. E-mail dharats{at}post.tau.ac.il
AbstractAlthough lipid
oxidation plays a major role in atherogenesis, the role of antioxidants
in the prevention and treatment of the process is not clear.
Apolipoprotein (apo) Edeficient mice develop spontaneous
atherosclerotic lesions in major arteries. The presence of oxidized
lipoprotein epitopes in the lesion suggests that oxidation reactions
are involved in atherogenesis in this mouse model, but the
inhibitory effect of antioxidants on atherogenesis in the
model is controversial. To test the effect of dietary antioxidants on
atherogenesis, male apoE-deficient mice (n=15) were fed a standard chow
diet supplemented with 0.05%
-tocopherol and 0.05%
all-trans ß-carotene. A control group (n=15) received no antioxidant
supplement. At the end of the trial, mice consuming vitamins had 5x
more plasma vitamin E but undetectable ß-carotene levels. However,
liver levels of the ß-carotene metabolite, retinyl palmitate, were
higher in antioxidant-treated mice compared with control mice. The
antioxidants had no effect on lipoprotein or on plasma
antioxidatively modified low density lipoproteins (anti-oxLDL)
antibody levels. The vitamins had a small but insignificant effect on
lipoprotein resistance to ex vivo oxidation, determined by a longer lag
period of conjugated diene formation. Atherosclerosis,
determined by the lesion size at the aortic sinus, was insignificantly
suppressed in antioxidant-treated mice (mean area±SE, 20 000±7129
versus 13 281±5861 µm2; P=0.40).
The aortic atherosclerotic lesion area was similar in both experimental
groups (2.55±0.65% and 2.08±0.5% of total aortic area in the
control and antioxidant group, respectively; P=0.58).
The results of the current study suggest that moderate levels of
synthetic antioxidant vitamins have no effect on atherogenesis in
apoE-deficient mice.
Key Words: atherosclerosis oxidation antioxidants ß-carotene
-tocopherol antibodies mouse apoE
This article has been cited by other articles:
![]() |
A. Harari, D. Harats, D. Marko, H. Cohen, I. Barshack, Y. Kamari, A. Gonen, Y. Gerber, A. Ben-Amotz, and A. Shaish A 9-cis {beta}-Carotene-Enriched Diet Inhibits Atherogenesis and Fatty Liver Formation in LDL Receptor Knockout Mice J. Nutr., October 1, 2008; 138(10): 1923 - 1930. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Yi and N. Maeda {alpha}-Lipoic Acid Prevents the Increase in Atherosclerosis Induced by Diabetes in Apolipoprotein E-Deficient Mice Fed High-Fat/Low-Cholesterol Diet. Diabetes, August 1, 2006; 55(8): 2238 - 2244. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gavrila, W. G. Li, M. L. McCormick, M. Thomas, A. Daugherty, L. A. Cassis, F. J. Miller Jr, L. W. Oberley, K. C. Dellsperger, and N. L. Weintraub Vitamin E Inhibits Abdominal Aortic Aneurysm Formation in Angiotensin II-Infused Apolipoprotein E-Deficient Mice Arterioscler Thromb Vasc Biol, August 1, 2005; 25(8): 1671 - 1677. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Waddington, I. B Puddey, and K. D Croft Red wine polyphenolic compounds inhibit atherosclerosis in apolipoprotein E-deficient mice independently of effects on lipid peroxidation Am. J. Clinical Nutrition, January 1, 2004; 79(1): 54 - 61. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Griendling and G. A. FitzGerald Oxidative Stress and Cardiovascular Injury: Part II: Animal and Human Studies Circulation, October 28, 2003; 108(17): 2034 - 2040. [Full Text] [PDF] |
||||
![]() |
M. Xia, W. H. Ling, J. Ma, D. D. Kitts, and J. Zawistowski Supplementation of Diets with the Black Rice Pigment Fraction Attenuates Atherosclerotic Plaque Formation in Apolipoprotein E Deficient Mice J. Nutr., March 1, 2003; 133(3): 744 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Schwenke, L. L. Rudel, M. G. Sorci-Thomas, and M. J. Thomas {alpha}-Tocopherol protects against diet induced atherosclerosis in New Zealand white rabbits J. Lipid Res., November 1, 2002; 43(11): 1927 - 1938. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. George, A. Afek, A. Shaish, H. Levkovitz, N. Bloom, T. Cyrus, L. Zhao, C. D. Funk, E. Sigal, and D. Harats 12/15-Lipoxygenase Gene Disruption Attenuates Atherogenesis in LDL Receptor-Deficient Mice Circulation, October 2, 2001; 104(14): 1646 - 1650. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Meilhac, S. Ramachandran, K. Chiang, N. Santanam, and S. Parthasarathy Role of Arterial Wall Antioxidant Defense in Beneficial Effects of Exercise on Atherosclerosis in Mice Arterioscler Thromb Vasc Biol, October 1, 2001; 21(10): 1681 - 1688. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Qureshi, W. A. Salser, R. Parmar, and E. E. Emeson Novel Tocotrienols of Rice Bran Inhibit Atherosclerotic Lesions in C57BL/6 ApoE-Deficient Mice J. Nutr., October 1, 2001; 131(10): 2606 - 2618. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Dwyer, M. Navab, K. M. Dwyer, K. Hassan, P. Sun, A. Shircore, S. Hama-Levy, G. Hough, X. Wang, T. Drake, et al. Oxygenated Carotenoid Lutein and Progression of Early Atherosclerosis : The Los Angeles Atherosclerosis Study Circulation, June 19, 2001; 103(24): 2922 - 2927. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Y. Fan, K. S. Ramos, and R. S. Chapkin Dietary {{gamma}}-Linolenic Acid Suppresses Aortic Smooth Muscle Cell Proliferation and Modifies Atherosclerotic Lesions in Apolipoprotein E Knockout Mice J. Nutr., June 1, 2001; 131(6): 1675 - 1681. [Abstract] [Full Text] |
||||
![]() |
S. R. Thomas, S. B. Leichtweis, K. Pettersson, K. D. Croft, T. A. Mori, A. J. Brown, and R. Stocker Dietary Cosupplementation With Vitamin E and Coenzyme Q10 Inhibits Atherosclerosis in Apolipoprotein E Gene Knockout Mice Arterioscler Thromb Vasc Biol, April 1, 2001; 21(4): 585 - 593. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Meagher, O. P. Barry, J. A. Lawson, J. Rokach, and G. A. FitzGerald Effects of Vitamin E on Lipid Peroxidation in Healthy Persons JAMA, March 7, 2001; 285(9): 1178 - 1182. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Collins, W. P. Meehan, U. Kintscher, S. Jackson, S. Wakino, G. Noh, W. Palinski, W. A. Hsueh, and R. E. Law Troglitazone Inhibits Formation of Early Atherosclerotic Lesions in Diabetic and Nondiabetic Low Density Lipoprotein Receptor-Deficient Mice Arterioscler Thromb Vasc Biol, March 1, 2001; 21(3): 365 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Terasawa, Z. Ladha, S. W. Leonard, J. D. Morrow, D. Newland, D. Sanan, L. Packer, M. G. Traber, and R. V. Farese Jr. Increased atherosclerosis in hyperlipidemic mice deficient in alpha -tocopherol transfer protein and vitamin E PNAS, November 22, 2000; (2000) 240462697. [Abstract] [Full Text] |
||||
![]() |
T. M. Black, P. Wang, N. Maeda, and R. A. Coleman Palm Tocotrienols Protect ApoE +/- Mice from Diet-Induced Atheroma Formation J. Nutr., October 1, 2000; 130(10): 2420 - 2426. [Abstract] [Full Text] |
||||
![]() |
S. R. Lentz, R. A. Erger, S. Dayal, N. Maeda, M. R. Malinow, D. D. Heistad, and F. M. Faraci Folate dependence of hyperhomocysteinemia and vascular dysfunction in cystathionine beta -synthase-deficient mice Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H970 - H975. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Parthasarathy, N. Santanam, S. Ramachandran, and O. Meilhac Oxidants and antioxidants in atherogenesis: an appraisal J. Lipid Res., December 1, 1999; 40(12): 2143 - 2157. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Terasawa, Z. Ladha, S. W. Leonard, J. D. Morrow, D. Newland, D. Sanan, L. Packer, M. G. Traber, and R. V. Farese Jr. Increased atherosclerosis in hyperlipidemic mice deficient in alpha -tocopherol transfer protein and vitamin E PNAS, December 5, 2000; 97(25): 13830 - 13834. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |